Orrick Advised Digital+ Partners on Investment in U.S. Driving Technology Innovator Cellcontrol

August.09.2018

Deutsch: Orrick berät Digital+ Partners bei Investment in U.S. Tech-Innovator Cellcontrol 

Orrick advised B2B technology investor Digital+ GmbH on its investment in Cellcontrol, a U.S.-based developer and provider of distracted driving prevention technology.

Based in Munich and Frankfurt, Digital+ is a growth equity investor focused on B2B technology companies. They invest in companies with best-in-class technologies and help scale them into digital leaders in Germany and internationally. Most recently, Digital+ successfully closed a major growth fund with a total of €350m.

Cellcontrol provides solutions for preventing distraction by mobile phones during work processes and while driving vehicles. Established in 2009, the company’s “machine vision” distracted driving prevention platform eliminates talking, texting, and browsing on any mobile device while a vehicle is in motion.

Digital+ was advised by an Orrick team led by Munich-based M&A and private equity partner Thomas Schmid. The team also included partners Stefan Schultes-Schnitzlein (tax, Düsseldorf) and Tal Hacohen (M&A and private equity, New York), and associates Jonathan Chou (Technology Companies Group, New York) and Stephen Lessard (tax, New York).